"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to TARA. [ FAQ on what and how to ask] For non-TARA questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Jesse Shefferman
Headquarter: 345 Park Avenue South, 3rd Floor, New York, NY, United States, 10010
Industry: Biotechnology, Investment Track: cell therapy - small, Employees: 46
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.
My Watchlist
